Successful Treatment With Rituximab of an Epstein‐Barr Virus–Associated Leiomyosarcoma Occurring After Liver Transplantation

Leiomyosarcoma Epstein-Barr Virus Infections Herpesvirus 4, Human Lymphoproliferative Disorders Liver Transplantation Antibodies, Monoclonal, Murine-Derived 03 medical and health sciences Postoperative Complications 0302 clinical medicine Child, Preschool Humans Immunologic Factors Female Rituximab
DOI: 10.1097/mpg.0b013e31826f2786 Publication Date: 2014-01-01T08:16:57Z